The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: Implications for pharmacological models of parkinsonian tremor
Keywords: ANOVA; analysis of variance; DA; dopamine; DAB; diaminobenzidine; DMSO; dimethylsulfoxide; EMG; electromyographic; HD; Huntington's disease; KO; knockout; NE; norepinephrine; PBS; phosphate buffered saline; TBZ; tetrabenazine; TJM; tremulous jaw movemen